Tenon Medical, Inc. Cash Flow Statement
TNON|4 years of annual SEC 10-K data (FY2022-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 4 fiscal years. All figures from audited SEC 10-K filings.
Tenon Medical, Inc. used $10M in operating cash flow and negative free cash flow of $10M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -2.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income | -$13.7M | -$15.6M | -$18.9M | -$7.0M |
| Depreciation & Amortization | $408.0K | $199.0K | $78.0K | $2.0K |
| Operating Cash Flow | -$9.9M | -$12.2M | -$12.0M | -$4.3M |
| Capital Expenditures | $186.0K | $361.0K | - | $102.0K |
| Free Cash Flow | -$10.1M | -$12.5M | - | -$4.4M |
| FCF Margin | -307.1% | -428.4% | - | -2746.3% |